Showing results (31-40 of 139) with videos related to
Sort By:
Pageof 14
Current Protocols in Pharmacology|February 2, 2012
Characterization of CGRP receptor bindingAlex C Conner, Debbie L Hay, David R PoynerTrends in Pharmacological Sciences|December 12, 2018
New Insights into the Regulation of CGRP-Family ReceptorsJoseph J Gingell, Erica R Hendrikse, Debbie L HayBritish Journal of Pharmacology|June 2, 2021
CGRP receptor antagonists for migraine. Are they also AMY<sub>1</sub> receptor antagonists?Michael L Garelja, Christopher S Walker, Debbie L HayAmerican Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 10, 2021
Amylin antibodies frequently display cross-reactivity with CGRP: characterization of eight amylin antibodiesTayla A Rees, Debbie L Hay, Christopher S WalkerThe Journal of Biological Chemistry|February 21, 2016
Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINSSang-Min Lee, Debbie L Hay, Augen A PioszakInternational Journal of Molecular Sciences|January 21, 2023
Comment on Yoo et al. Amylin Protein Expression in the Rat Brain and Neuro-2a Cells. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 4348Tayla A Rees, Debbie L Hay, Christopher S WalkerRegulatory Peptides|April 2, 2003
Desensitisation of adrenomedullin and CGRP receptorsDebbie L Hay, David R Poyner, David M SmithEndocrine-Related Cancer|November 6, 2010
Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challengesDebbie L Hay, Christopher S Walker, David R PoynerExpert Opinion on Drug Discovery|March 14, 2013
CGRP receptor antagonists: design and screeningDavid R Poyner, Debbie L Hay, Alex C ConnerEndocrinology|October 31, 2013
Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptorsJoseph J Gingell, Erica R Burns, Debbie L HayPageof 14